Search Videos and More
News
Advanced Coronary Revascularization for Severe Coronary Disease
Broadly, coronary revascularization is a surgical intervention used to treat blocked arteries. The method allows a wide range of patients to avoid the trauma of open-heart surgery and restore healthy blood flow to the heart.
Podcast
Preventing the Progression of Atherosclerosis
During his work in the Coronary Care Unit as a resident, Prediman K. Shah, MD, the Shapell and Webb Family Chair in Clinical Cardiology at Cedars-Sinai, was surprised by how many patients came in with heart attack, cardiogenic shock and unstable angina. This realization led to his decades of research on atherosclerosis and related conditions.
Podcast
The Female Experience with Heart Disease
Many of the diagnostic and treatment algorithms for heart disease were originally created by men, for men. But in 1984, more women died of heart disease than men for the first time. Since then, experts have turned their attention to this condition in women, including Noel Bairey Merz, MD, Director of the Barbra Streisand Women’s Heart Center.
News
Despite Pandemic, 2020 Brought Increase in Heart Transplants
Cardiothoracic Surgeons at the Smidt Heart Institute Performed 128 Adult Heart Transplants in 2020, More Than Any Other Center in the Nation.
News
New Center's Mission: Predict, Prevent Sudden Cardiac Arrest
Smidt Heart Institute Launches Comprehensive Center for Cardiac Arrest Prevention to Investigate Complex Solutions to a Historically Lethal Problem
News
European Heart Journal: Cell Infusions Benefit Heart Patients
Three years after the ALLSTAR clinical trial ended prematurely, the study's data shows that treatments of cardiosphere-derived cells -- the same cells used as an experimental therapy tested in COVID-19 patients -- demonstrated unexpected promise in heart attack survivors.
Video
The ALLSTAR Clinical Trial Explained
More than three years after a clinical trial was prematurely ended for failing to show progress in healing heart attack scars, a prominent peer-reviewed journal is publishing some surprising results showing that the heart cell treatment does benefit patients.
News
Cardiac Side Effects Found in 2 COVID-19 Drugs
About 12% of nearly 100 patients hospitalized with COVID-19 (coronavirus) developed a cardiac abnormality after receiving hydroxychloroquine and azithromycin—two drugs currently being administered to some coronavirus patients worldwide—according to an uncontrolled study reported May 28 by Cedars-Sinai in the Journal of the American Heart Association.
News
Bairey Merz, MD, Wins Pioneer in Medicine Award
Noel Bairey Merz, MD, has a stellar academic background, including degrees from the University of Chicago and Harvard Medical School. But she jokes that she got a crucial boost in her pioneering research into women's heart disease by learning from someone with a different sort of pedigree.
News
Cardio-Oncology Gets to the Heart of Cancer Patients' Health
Cedars-Sinai experts in the Smidt Heart Institute are making heart health a priority for cancer survivors and patients through the Cardio-Oncology Program. The program is more relevant than ever because cancer patients are living longer than ever. The five-year relative survival rate for all cancers combined has increased substantially since the early 1960s, from 39% to 70% among white patients and from 27% to 64% among African American patients.
BROADCASTMED